Paul J. Clark

2.7k total citations
88 papers, 1.7k citations indexed

About

Paul J. Clark is a scholar working on Epidemiology, Hepatology and Emergency Medical Services. According to data from OpenAlex, Paul J. Clark has authored 88 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Epidemiology, 57 papers in Hepatology and 7 papers in Emergency Medical Services. Recurrent topics in Paul J. Clark's work include Liver Disease Diagnosis and Treatment (49 papers), Hepatitis C virus research (35 papers) and Liver Disease and Transplantation (24 papers). Paul J. Clark is often cited by papers focused on Liver Disease Diagnosis and Treatment (49 papers), Hepatitis C virus research (35 papers) and Liver Disease and Transplantation (24 papers). Paul J. Clark collaborates with scholars based in Australia, United States and United Kingdom. Paul J. Clark's co-authors include Patricia C. Valery, John G. McHutchison, Jessica L. Petrick, Katherine A. McGlynn, Freddie Bray, Mathieu Laversanne, Alexander Thompson, Keyur Patel, Peter D. Baade and Andrew J. Muir and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Paul J. Clark

81 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul J. Clark Australia 22 1.0k 888 254 174 157 88 1.7k
Katherine Stuart Australia 23 834 0.8× 859 1.0× 180 0.7× 253 1.5× 81 0.5× 73 1.6k
Eun Sun Jang South Korea 25 983 1.0× 1.1k 1.2× 329 1.3× 383 2.2× 197 1.3× 135 2.0k
Jeong‐Ju Yoo South Korea 23 1.0k 1.0× 1.4k 1.5× 242 1.0× 337 1.9× 127 0.8× 172 2.0k
Michelle M. Richardson United States 12 571 0.6× 673 0.8× 170 0.7× 299 1.7× 75 0.5× 31 1.3k
Walid S. Ayoub United States 21 992 1.0× 1.1k 1.2× 163 0.6× 388 2.2× 167 1.1× 65 2.0k
Nghia Nguyen United States 28 513 0.5× 958 1.1× 188 0.7× 344 2.0× 140 0.9× 86 1.8k
Gopal Krishna Dhali India 18 594 0.6× 1.0k 1.1× 372 1.5× 480 2.8× 152 1.0× 82 2.0k
Maud Lemoine France 31 2.3k 2.2× 2.9k 3.3× 302 1.2× 365 2.1× 123 0.8× 122 3.5k
Sheng‐Shun Yang Taiwan 27 1.9k 1.8× 1.9k 2.1× 318 1.3× 662 3.8× 268 1.7× 149 3.2k
Aftab Ala United Kingdom 20 339 0.3× 346 0.4× 256 1.0× 209 1.2× 201 1.3× 83 2.3k

Countries citing papers authored by Paul J. Clark

Since Specialization
Citations

This map shows the geographic impact of Paul J. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Clark more than expected).

Fields of papers citing papers by Paul J. Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Clark. The network helps show where Paul J. Clark may publish in the future.

Co-authorship network of co-authors of Paul J. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Clark. A scholar is included among the top collaborators of Paul J. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Clark. Paul J. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skoien, Richard, Günter Härtel, James O’Beirne, et al.. (2024). Rising hospital admissions for alcohol-related cirrhosis and the impact of sex and comorbidity – a data linkage study. Public Health. 232. 178–187. 1 indexed citations
2.
3.
Pham, Lily, Paul J. Clark, Graeme A. Macdonald, et al.. (2024). Colorectal cancer screening participation in First Nations populations worldwide: a systematic review and data synthesis. EClinicalMedicine. 73. 102666–102666. 2 indexed citations
4.
Howell, Jessica, Paula Binks, Paul J. Clark, et al.. (2024). Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action. The Medical Journal of Australia. 221(5). 230–235. 4 indexed citations
5.
Clark, Paul J., Patricia C. Valery, Simone I. Strasser, et al.. (2023). Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care. Journal of Gastroenterology and Hepatology. 39(3). 568–575. 2 indexed citations
6.
Shahid, Shaouli, Christina M. Bernardes, Maree Toombs, et al.. (2022). Partnering with support persons and clinicians to improve the health care experiences of patients with cirrhosis. Journal of Clinical Nursing. 32(11-12). 2559–2574. 5 indexed citations
7.
Valery, Patricia C., Christina M. Bernardes, Katherine Stuart, et al.. (2020). <p>Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC)</p>. Patient Preference and Adherence. Volume 14. 599–611. 17 indexed citations
8.
Valery, Patricia C., Steven McPhail, Katherine Stuart, et al.. (2020). Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis. Internal Medicine Journal. 51(5). 691–698. 17 indexed citations
9.
Valery, Patricia C., Elizabeth E. Powell, Michael L. Volk, et al.. (2015). Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease. BMJ Open. 5(4). e007451–e007451. 61 indexed citations
10.
Naggie, Susanna, Anu Osinusi, Antonios Katsounas, et al.. (2012). Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B -unfavorable genotype patients: Impaired viral kinetics and therapeutic response. Hepatology. 56(2). 444–454. 55 indexed citations
11.
Clark, Paul J. & Alexander Thompson. (2011). Host genomics and HCV treatment response. Journal of Gastroenterology and Hepatology. 27(2). 212–222. 25 indexed citations
12.
Clark, Paul J., Alexander Thompson, Stuart C. Gordon, et al.. (2011). PREDICTORS OF CONSENT TO PHARMACOGENOMICS TESTING IN THE IDEAL STUDY. Hepatology. 54.
13.
Thompson, Alexander, Paul J. Clark, David M. Vock, et al.. (2011). PREDICTING PEGINTERFERON-alpha AND RIBAVIRIN TREATMENT RESPONSE IN GENOTYPE 1 HCV PATIENTS - SIMPLE NOMOGRAMS TO SUPPORT CLINICIANS. Hepatology. 54. 95–8. 1 indexed citations
14.
Golden‐Mason, Lucy, Kiran Bambha, Linling Cheng, et al.. (2011). Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C. Hepatology. 54(5). 1559–1569. 56 indexed citations
15.
Gellad, Ziad F., Susanna Naggie, Shelby D. Reed, et al.. (2011). The Cost-Effectiveness of a Telaprevir-Inclusive Regimen as Initial Therapy for Genotype 1 Hepatitis C Infection in Individuals with the Cc Il-28B Polymorphism. Hepatology. 54. 13 indexed citations
16.
Thompson, Alexander, Paul J. Clark, Hans L. Tillmann, et al.. (2011). Il28B C/c Genotype Is Predictive of >= 1 Log10 Iu/ml Reduction in Plasma Hcv Rna After 4 Weeks of Peginterferon (Pegifn) and Ribavirin (Rbv) Therapy: Implications for the Use of the Lead-In Strategy for Direct-Acting Antiviral-Based Treatment Regimens. Hepatology. 54. 3 indexed citations
17.
Clark, Paul J., et al.. (2011). Vitamin D and Treatment Response in African American Patients with Hcv Genotype 1. Hepatology. 54. 5 indexed citations
18.
Thompson, Alex J., Rosanna Santoro, Valeria Piazzolla, et al.. (2010). Itpa Genetic Variants Are Protective Against Anemia During Antiviral Therapy for G2/3 Hcv, But Do Not Decrease the Need for Rbv Dose Reduction or Increase Svr. Hepatology. 52(4). 1 indexed citations
19.
Clark, Paul J., et al.. (1990). Limitations on the use of immobilized bacterial biofilms for enzymically-mediated uranyl ion accumulation. Biotechnology Techniques. 4(5). 345–350. 11 indexed citations
20.
Clark, Paul J., et al.. (1957). Mercury content of apples.. 38. 843–848. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine Stuart Breakdown of academic impact, for papers by Eun Sun Jang Breakdown of academic impact, for papers by Jeong‐Ju Yoo Breakdown of academic impact, for papers by Michelle M. Richardson Breakdown of academic impact, for papers by Walid S. Ayoub Breakdown of academic impact, for papers by Nghia Nguyen Breakdown of academic impact, for papers by Gopal Krishna Dhali Breakdown of academic impact, for papers by Maud Lemoine Breakdown of academic impact, for papers by Sheng‐Shun Yang Breakdown of academic impact, for papers by Aftab Ala
Rankless by CCL
2026